Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

  • The following term was ignored: -
  • See the search details.
1.

Mice expressing reduced levels of hepatic glucose-6-phosphatase-α activity do not develop age-related insulin resistance or obesity.

Kim GY, Lee YM, Cho JH, Pan CJ, Jun HS, Springer DA, Mansfield BC, Chou JY.

Hum Mol Genet. 2015 Sep 15;24(18):5115-25. doi: 10.1093/hmg/ddv230. Epub 2015 Jun 18.

2.

Is C771G polymorphism of MLX interacting protein-like (MLXIPL) gene a novel genetic risk factor for non-alcoholic fatty liver disease?

Seifi M, Ghasemi A, Namipashaki A, Samadikuchaksaraei A.

Cell Mol Biol (Noisy-le-grand). 2014;60(3):37-42.

PMID:
26177557
3.

Hepatic glucose sensing is required to preserve β cell glucose competence.

Seyer P, Vallois D, Poitry-Yamate C, Schütz F, Metref S, Tarussio D, Maechler P, Staels B, Lanz B, Grueter R, Decaris J, Turner S, da Costa A, Preitner F, Minehira K, Foretz M, Thorens B.

J Clin Invest. 2013 Apr;123(4):1662-76. doi: 10.1172/JCI65538. Epub 2013 Mar 15.

4.

De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health.

Eissing L, Scherer T, Tödter K, Knippschild U, Greve JW, Buurman WA, Pinnschmidt HO, Rensen SS, Wolf AM, Bartelt A, Heeren J, Buettner C, Scheja L.

Nat Commun. 2013;4:1528. doi: 10.1038/ncomms2537.

5.

Isoflavones as a smart curer for non-alcoholic fatty liver disease and pathological adiposity via ChREBP and Wnt signaling.

Kim MH, Kang KS.

Prev Med. 2012 May;54 Suppl:S57-63. doi: 10.1016/j.ypmed.2011.12.018. Epub 2011 Dec 28. Review.

PMID:
22227283
6.

High prevalence of an anti-hypertriglyceridemic variant of the MLXIPL gene in Central Asia.

Nakayama K, Yanagisawa Y, Ogawa A, Ishizuka Y, Munkhtulga L, Charupoonphol P, Supannnatas S, Kuartei S, Chimedregzen U, Koda Y, Ishida T, Kagawa Y, Iwamoto S.

J Hum Genet. 2011 Dec;56(12):828-33. doi: 10.1038/jhg.2011.109. Epub 2011 Sep 22.

PMID:
21938000
7.

ChREBP expression in the liver, adipose tissue and differentiated preadipocytes in human obesity.

Hurtado del Pozo C, Vesperinas-García G, Rubio MÁ, Corripio-Sánchez R, Torres-García AJ, Obregon MJ, Calvo RM.

Biochim Biophys Acta. 2011 Dec;1811(12):1194-200. doi: 10.1016/j.bbalip.2011.07.016. Epub 2011 Jul 30.

8.

Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemia.

Caron S, Verrijken A, Mertens I, Samanez CH, Mautino G, Haas JT, Duran-Sandoval D, Prawitt J, Francque S, Vallez E, Muhr-Tailleux A, Berard I, Kuipers F, Kuivenhoven JA, Biddinger SB, Taskinen MR, Van Gaal L, Staels B.

Arterioscler Thromb Vasc Biol. 2011 Mar;31(3):513-9. doi: 10.1161/ATVBAHA.110.220723. Epub 2010 Dec 23.

PMID:
21183731
9.

Transgenic expression of a mutated cyclin-dependent kinase 4 (CDK4/R24C) in pancreatic beta-cells prevents progression of diabetes in db/db mice.

Miyawaki K, Inoue H, Keshavarz P, Mizuta K, Sato A, Sakamoto Y, Moritani M, Kunika K, Tanahashi T, Itakura M.

Diabetes Res Clin Pract. 2008 Oct;82(1):33-41. doi: 10.1016/j.diabres.2008.06.014. Epub 2008 Aug 3.

PMID:
18678431
10.

Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.

Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, Cooper GM, Roos C, Voight BF, Havulinna AS, Wahlstrand B, Hedner T, Corella D, Tai ES, Ordovas JM, Berglund G, Vartiainen E, Jousilahti P, Hedblad B, Taskinen MR, Newton-Cheh C, Salomaa V, Peltonen L, Groop L, Altshuler DM, Orho-Melander M.

Nat Genet. 2008 Feb;40(2):189-97. doi: 10.1038/ng.75. Epub 2008 Jan 13. Erratum in: Nat Genet. 2008 Nov;40(11):1384.

Supplemental Content

Loading ...
Support Center